Antiplatelet and Anticoagulation Therapy in Cardiovascular and Pulmonary Embolism Transcatheter Interventions, an Issue of Interventional Cardiology Clinics (The Clinics: Internal Medicine) / Paz, Luis Ortega (EDT)

ホーム
> 洋書
> 英文書
> Medical

Antiplatelet and Anticoagulation Therapy in Cardiovascular and Pulmonary Embolism Transcatheter Interventions, an Issue of Interventional Cardiology Clinics (The Clinics: Internal Medicine)

個数：

電子版価格
¥26,104

電子版あり

Antiplatelet and Anticoagulation Therapy in Cardiovascular and Pulmonary Embolism Transcatheter Interventions, an Issue of Interventional Cardiology Clinics (The Clinics: Internal Medicine)

Paz, Luis Ortega (EDT)

ウェブストア価格 ¥14,472（本体¥13,157）
Churchill Livingstone（2024/09発売）
外貨定価 US$ 68.99
ポイント 131pt

在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
通常6～9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
【重要ご説明事項】
1. 納期遅延や、ご入手不能となる場合がございます。
2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
3. 美品のご指定は承りかねます。

●3Dセキュア導入とクレジットカードによるお支払いについて

【入荷遅延について】
世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。

◆画像の表紙や帯等は実物とは異なる場合があります。

◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
また、洋書販売価格は、ご注文確定時点での日本円価格となります。
ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。

製本 Hardcover:ハードカバー版／ページ数 240 p.
言語 ENG
商品コード 9780443296727
DDC分類 616.12

Full Description

In this issue of Interventional Cardiology Clinics, guest editor Dr. Luis Ortega Paz brings his considerable expertise to the topic of Antiplatelet and Anticoagulation Therapy in Cardiovascular and Pulmonary Embolism Transcatheter Interventions. Top experts in the field discuss regulation of platelet activation and coagulation; genetic determinants of P2Y12 inhibitors and clinical implications; switching P2Y12 receptor inhibiting therapies; high bleeding risk in patients undergoing coronary and structural heart interventions; and much more.

Contains 13 relevant, practice-oriented topics including antithrombotic therapy in atrial fibrillation patients undergoing coronary stenting; antithrombotic therapy in patients undergoing transcatheter aortic valve replacement; antithrombotic therapy in patients undergoing peripheral artery interventions; antiplatelet therapy in women; and more.
Provides in-depth clinical reviews on antiplatelet and anticoagulation therapy in cardiovascular and pulmonary embolism transcatheter interventions, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Regulation of Platelet Activation and Coagulation: Current Concepts, Novel Targets, and Therapies
Genetic Determinants of Response to P2Y12 Inhibitors and Clinical Implications
High Bleeding Risk in Patients Undergoing Coronary and Structural Heart Interventions
Antithrombotic Therapy in Patients with Chronic Coronary Syndromes
Antithrombotic Therapy in Acute Coronary Syndrome
Antithrombotic Therapy in Patients with Complex Percutaneous Coronary Intervention and Cardiogenic Shock
Antiplatelet Therapy in Patients Requiring Oral Anticoagulation and Undergoing Percutaneous Coronary Intervention
Antithrombotic Therapy in Patients Undergoing Percutaneous Left Atrial Appendage Occlusion
Antithrombotic Therapy in Patients Undergoing Peripheral Artery Interventions
Anticoagulant Therapy in Patients Undergoing Acute Pulmonary Embolism Interventions
Considerations in Antiplatelet Therapy in Women Undergoing Treatment of Acute Coronary Syndrome or Percutaneous Coronary Intervention